Magnesium in PDB 4raq: Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Enzymatic activity of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
All present enzymatic activity of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents:
2.4.2.8;
Protein crystallography data
The structure of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents, PDB code: 4raq
was solved by
D.T.Keough,
D.Hockov,
Z.Janeba,
T.-H.Wang,
L.Naesens,
M.D.Edstein,
M.Chavchich,
L.W.Guddat,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
58.90 /
2.53
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
76.328,
92.605,
115.013,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.7 /
26.9
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
(pdb code 4raq). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 8 binding sites of Magnesium where determined in the
Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents, PDB code: 4raq:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Magnesium binding site 1 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 1 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg302
b:69.4
occ:1.00
|
O
|
A:HOH430
|
1.8
|
79.1
|
1.0
|
O
|
A:HOH410
|
2.3
|
55.8
|
1.0
|
OAG
|
A:3L8301
|
2.5
|
61.9
|
1.0
|
OD1
|
A:ASP193
|
2.9
|
58.5
|
1.0
|
CAJ
|
A:3L8301
|
3.5
|
71.5
|
1.0
|
PBA
|
A:3L8301
|
3.7
|
85.6
|
1.0
|
CAP
|
A:3L8301
|
3.7
|
83.8
|
1.0
|
OAT
|
A:3L8301
|
3.7
|
79.6
|
1.0
|
CG
|
A:ASP193
|
3.8
|
55.7
|
1.0
|
OD2
|
A:ASP193
|
4.0
|
58.6
|
1.0
|
O
|
A:HOH431
|
4.1
|
46.9
|
1.0
|
OAF
|
A:3L8301
|
4.5
|
89.8
|
1.0
|
CAN
|
A:3L8301
|
4.6
|
61.1
|
1.0
|
N3
|
A:3L8301
|
4.6
|
53.9
|
1.0
|
O
|
A:ASP193
|
4.8
|
53.8
|
1.0
|
NH2
|
A:ARG199
|
4.8
|
76.2
|
1.0
|
OAC
|
A:3L8301
|
4.8
|
84.7
|
1.0
|
CAK
|
A:3L8301
|
4.9
|
65.5
|
1.0
|
|
Magnesium binding site 2 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 2 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg303
b:46.9
occ:1.00
|
O
|
A:HOH427
|
1.8
|
53.8
|
1.0
|
O
|
A:HOH428
|
2.4
|
53.6
|
1.0
|
OD1
|
A:ASP134
|
2.5
|
53.1
|
1.0
|
OD2
|
A:ASP134
|
2.9
|
60.6
|
1.0
|
CG
|
A:ASP134
|
3.0
|
51.2
|
1.0
|
OAT
|
A:3L8301
|
3.0
|
79.6
|
1.0
|
OE1
|
A:GLU133
|
3.1
|
49.2
|
1.0
|
OAC
|
A:3L8301
|
3.4
|
84.7
|
1.0
|
CD
|
A:GLU133
|
3.6
|
51.2
|
1.0
|
CAP
|
A:3L8301
|
3.7
|
83.8
|
1.0
|
OE2
|
A:GLU133
|
3.8
|
55.1
|
1.0
|
CAJ
|
A:3L8301
|
4.0
|
71.5
|
1.0
|
PBA
|
A:3L8301
|
4.2
|
85.6
|
1.0
|
CAK
|
A:3L8301
|
4.3
|
65.5
|
1.0
|
O
|
A:HOH422
|
4.4
|
59.1
|
1.0
|
CB
|
A:ASP134
|
4.4
|
46.4
|
1.0
|
CG
|
A:GLU133
|
4.6
|
41.9
|
1.0
|
O
|
A:ILE135
|
4.7
|
65.3
|
1.0
|
N
|
A:ASP134
|
4.7
|
57.0
|
1.0
|
CA
|
A:GLY69
|
4.8
|
42.1
|
1.0
|
N
|
A:ILE135
|
4.8
|
43.9
|
1.0
|
CAL
|
A:3L8301
|
4.8
|
56.5
|
1.0
|
CG2
|
A:ILE135
|
4.9
|
62.8
|
1.0
|
N
|
A:GLY69
|
4.9
|
53.6
|
1.0
|
OAG
|
A:3L8301
|
4.9
|
61.9
|
1.0
|
CG1
|
A:VAL66
|
4.9
|
48.0
|
1.0
|
O
|
A:LEU67
|
5.0
|
60.0
|
1.0
|
|
Magnesium binding site 3 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 3 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg302
b:73.1
occ:1.00
|
O
|
B:HOH422
|
2.1
|
64.5
|
1.0
|
O
|
B:HOH433
|
2.3
|
47.0
|
1.0
|
O
|
B:HOH407
|
2.3
|
72.4
|
1.0
|
OD1
|
B:ASP193
|
3.0
|
57.9
|
1.0
|
CAP
|
B:3L8301
|
3.5
|
72.2
|
1.0
|
OD2
|
B:ASP193
|
3.5
|
54.2
|
1.0
|
CG
|
B:ASP193
|
3.7
|
56.5
|
1.0
|
OAG
|
B:3L8301
|
3.7
|
0.4
|
1.0
|
PBA
|
B:3L8301
|
4.3
|
76.9
|
1.0
|
OAT
|
B:3L8301
|
4.6
|
64.5
|
1.0
|
O
|
B:ASP193
|
4.6
|
65.3
|
1.0
|
OE2
|
B:GLU196
|
4.7
|
73.5
|
1.0
|
CAJ
|
B:3L8301
|
4.8
|
59.9
|
1.0
|
|
Magnesium binding site 4 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 4 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg303
b:50.7
occ:1.00
|
O
|
B:HOH430
|
1.9
|
53.5
|
1.0
|
O
|
B:HOH431
|
2.0
|
44.7
|
1.0
|
O
|
B:HOH425
|
2.4
|
58.0
|
1.0
|
OD1
|
B:ASP134
|
2.4
|
59.3
|
1.0
|
OAC
|
B:3L8301
|
2.5
|
68.2
|
1.0
|
OE1
|
B:GLU133
|
2.9
|
56.2
|
1.0
|
CG
|
B:ASP134
|
3.2
|
57.4
|
1.0
|
OD2
|
B:ASP134
|
3.2
|
68.5
|
1.0
|
CAK
|
B:3L8301
|
3.4
|
57.6
|
1.0
|
OAT
|
B:3L8301
|
3.6
|
64.5
|
1.0
|
CD
|
B:GLU133
|
3.8
|
57.6
|
1.0
|
PBA
|
B:3L8301
|
3.8
|
76.9
|
1.0
|
CAP
|
B:3L8301
|
4.0
|
72.2
|
1.0
|
CAJ
|
B:3L8301
|
4.0
|
59.9
|
1.0
|
OE2
|
B:GLU133
|
4.3
|
58.9
|
1.0
|
CG2
|
B:ILE135
|
4.5
|
48.0
|
1.0
|
NAX
|
B:3L8301
|
4.6
|
54.4
|
1.0
|
O
|
B:HOH432
|
4.6
|
57.8
|
1.0
|
CB
|
B:ASP134
|
4.6
|
48.9
|
1.0
|
CAL
|
B:3L8301
|
4.6
|
50.8
|
1.0
|
O
|
B:ILE135
|
4.6
|
61.8
|
1.0
|
N
|
B:ILE135
|
4.7
|
53.1
|
1.0
|
CG
|
B:GLU133
|
4.7
|
50.1
|
1.0
|
OAG
|
B:3L8301
|
4.8
|
0.4
|
1.0
|
OAF
|
B:3L8301
|
4.8
|
48.0
|
1.0
|
CA
|
B:GLY69
|
4.8
|
52.7
|
1.0
|
N
|
B:ASP134
|
4.9
|
38.9
|
1.0
|
O
|
B:HOH433
|
4.9
|
47.0
|
1.0
|
N
|
B:GLY69
|
4.9
|
49.1
|
1.0
|
|
Magnesium binding site 5 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 5 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg302
b:57.5
occ:1.00
|
O
|
C:HOH430
|
2.0
|
52.2
|
1.0
|
O
|
C:HOH431
|
2.5
|
50.1
|
1.0
|
OD1
|
C:ASP193
|
2.7
|
69.7
|
1.0
|
OD2
|
C:ASP193
|
2.8
|
66.4
|
1.0
|
O
|
C:HOH432
|
3.0
|
70.2
|
1.0
|
CG
|
C:ASP193
|
3.2
|
62.4
|
1.0
|
OAF
|
C:3L8301
|
3.2
|
71.5
|
1.0
|
OAT
|
C:3L8301
|
4.1
|
96.7
|
1.0
|
NH2
|
C:ARG199
|
4.2
|
62.6
|
1.0
|
CAP
|
C:3L8301
|
4.3
|
0.9
|
1.0
|
PBA
|
C:3L8301
|
4.4
|
86.2
|
1.0
|
OE2
|
C:GLU196
|
4.6
|
62.5
|
1.0
|
N
|
C:ASN195
|
4.6
|
49.5
|
1.0
|
CB
|
C:ASP193
|
4.7
|
51.2
|
1.0
|
CAJ
|
C:3L8301
|
4.7
|
82.3
|
1.0
|
O
|
C:ASP193
|
4.8
|
48.0
|
1.0
|
N
|
C:GLU196
|
4.9
|
56.1
|
1.0
|
|
Magnesium binding site 6 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 6 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 6 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg303
b:82.0
occ:1.00
|
OD1
|
C:ASP134
|
2.5
|
65.4
|
1.0
|
O
|
C:HOH413
|
2.9
|
65.2
|
1.0
|
CG
|
C:GLU133
|
3.1
|
68.0
|
1.0
|
OE1
|
C:GLU133
|
3.2
|
83.3
|
1.0
|
CG
|
C:ASP134
|
3.5
|
63.7
|
1.0
|
CD
|
C:GLU133
|
3.6
|
79.7
|
1.0
|
OD2
|
C:ASP134
|
3.7
|
67.2
|
1.0
|
CAK
|
C:3L8301
|
3.9
|
66.6
|
1.0
|
CG2
|
C:THR141
|
4.0
|
56.6
|
1.0
|
O
|
C:ILE135
|
4.0
|
60.6
|
1.0
|
CAM
|
C:3L8301
|
4.2
|
66.3
|
1.0
|
CG1
|
C:VAL66
|
4.2
|
46.4
|
1.0
|
N
|
C:ASP134
|
4.3
|
50.2
|
1.0
|
CB
|
C:GLU133
|
4.5
|
51.2
|
1.0
|
N
|
C:ILE135
|
4.6
|
53.7
|
1.0
|
OAC
|
C:3L8301
|
4.6
|
78.6
|
1.0
|
NAX
|
C:3L8301
|
4.6
|
59.9
|
1.0
|
CB
|
C:VAL66
|
4.7
|
51.8
|
1.0
|
CB
|
C:THR141
|
4.7
|
59.6
|
1.0
|
OE2
|
C:GLU133
|
4.8
|
78.4
|
1.0
|
CB
|
C:ASP134
|
4.8
|
55.5
|
1.0
|
CAJ
|
C:3L8301
|
4.8
|
82.3
|
1.0
|
OG1
|
C:THR141
|
4.9
|
66.5
|
1.0
|
CA
|
C:GLU133
|
4.9
|
41.9
|
1.0
|
|
Magnesium binding site 7 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 7 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 7 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg302
b:54.6
occ:1.00
|
OAC
|
D:3L8301
|
2.3
|
88.9
|
1.0
|
OD1
|
D:ASP134
|
2.4
|
54.2
|
1.0
|
O
|
D:HOH425
|
2.5
|
63.0
|
1.0
|
OE2
|
D:GLU133
|
2.9
|
59.0
|
1.0
|
CAJ
|
D:3L8301
|
2.9
|
75.4
|
1.0
|
OD2
|
D:ASP134
|
3.0
|
70.0
|
1.0
|
CG
|
D:ASP134
|
3.0
|
60.9
|
1.0
|
OE1
|
D:GLU133
|
3.1
|
55.4
|
1.0
|
CD
|
D:GLU133
|
3.2
|
54.7
|
1.0
|
CAK
|
D:3L8301
|
3.5
|
68.0
|
1.0
|
PBA
|
D:3L8301
|
3.5
|
75.1
|
1.0
|
CAP
|
D:3L8301
|
3.8
|
75.9
|
1.0
|
OAT
|
D:3L8301
|
3.8
|
78.0
|
1.0
|
OAG
|
D:3L8301
|
4.1
|
75.3
|
1.0
|
CG
|
D:GLU133
|
4.4
|
50.0
|
1.0
|
CB
|
D:ASP134
|
4.5
|
50.9
|
1.0
|
O
|
D:ILE135
|
4.6
|
51.0
|
1.0
|
O
|
D:HOH402
|
4.7
|
62.9
|
1.0
|
CG2
|
D:ILE135
|
4.7
|
44.8
|
1.0
|
N
|
D:ASP134
|
4.7
|
44.1
|
1.0
|
N
|
D:ILE135
|
4.7
|
55.3
|
1.0
|
NAX
|
D:3L8301
|
4.8
|
58.2
|
1.0
|
OAF
|
D:3L8301
|
4.8
|
41.7
|
1.0
|
N
|
D:GLY69
|
4.9
|
47.7
|
1.0
|
CAL
|
D:3L8301
|
4.9
|
50.1
|
1.0
|
O
|
D:HOH407
|
4.9
|
63.2
|
1.0
|
|
Magnesium binding site 8 out
of 8 in 4raq
Go back to
Magnesium Binding Sites List in 4raq
Magnesium binding site 8 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 8 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg303
b:50.2
occ:1.00
|
OD1
|
D:ASP193
|
2.1
|
62.1
|
1.0
|
O
|
D:HOH402
|
2.4
|
62.9
|
1.0
|
OAF
|
D:3L8301
|
2.5
|
41.7
|
1.0
|
CG
|
D:ASP193
|
2.9
|
59.0
|
1.0
|
OD2
|
D:ASP193
|
3.0
|
62.4
|
1.0
|
OAT
|
D:3L8301
|
3.5
|
78.0
|
1.0
|
PBA
|
D:3L8301
|
3.7
|
75.1
|
1.0
|
CAP
|
D:3L8301
|
3.8
|
75.9
|
1.0
|
NH2
|
D:ARG199
|
4.0
|
60.1
|
1.0
|
CAJ
|
D:3L8301
|
4.3
|
75.4
|
1.0
|
OAC
|
D:3L8301
|
4.3
|
88.9
|
1.0
|
CB
|
D:ASP193
|
4.4
|
56.6
|
1.0
|
O
|
D:ASP193
|
4.6
|
59.1
|
1.0
|
OAG
|
D:3L8301
|
4.9
|
75.3
|
1.0
|
C
|
D:ASP193
|
4.9
|
60.0
|
1.0
|
CZ
|
D:ARG199
|
4.9
|
52.0
|
1.0
|
N3
|
D:3L8301
|
5.0
|
60.7
|
1.0
|
|
Reference:
D.T.Keough,
D.Hockova,
Z.Janeba,
T.H.Wang,
L.Naesens,
M.D.Edstein,
M.Chavchich,
L.W.Guddat.
Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents. J.Med.Chem. V. 58 827 2015.
ISSN: ISSN 0022-2623
PubMed: 25494538
DOI: 10.1021/JM501416T
Page generated: Tue Aug 20 02:59:25 2024
|